SmartTRAK examines recent trends in breast implants and discusses their future impact on breast matrices.
Breast matrices, whether acellular dermal matrices (ADMs) or biosynthetics, have enabled improved outcomes in implant-based breast reconstruction and have contributed, in large part, to the revival of the prepectoral breast reconstruction technique. As the number of breast implant procedures has grown, so has the use of breast matrices. However, SmartTRAK believes the side effects and health consequences now associated with breast implants, while rare, will negatively impact breast implant usage and thus reduce the growth rate of breast matrices in 2022 and beyond.
In this informative Outlook article by Doug Devens, SmartTRAK's Product Director and Senior Editor, Wound, Doug covers:
- The Relationship between Breast Surgery and ADM Usage
- Trends in Implant Usage
- Recent Concerns that May Affect Breast Implant Usage
- The Future Outlook for 2022 and Beyond